MSI1 and glioblastoma: In pediatric GBM cells with elevated MSI1 expression, greater resistance to the combined drug treatment of temozolomide and valproic acid was observed, suggesting the potential to increase drug sensitivity by impairing MSI1 along with combinatorial drug treatment (Pötschke et al., 2020).